title: Investigation of the 22q11.2 candidate region in patients with midline facial defects with hypertelorism.
abstract: Midline facial defects with hypertelorism (MFDH) are mainly characterized by ocular hypertelorism and bifid nose. They are often associated with structural and functional anomalies of the central nervous system similar to those found in 22q11.2 deletion syndromes. In addition, there are some isolated reports of MFDH and 22q11.2 deletion. These findings suggest that MFDH may be part of the spectrum of 22q11.2 deletion syndromes. To test this hypothesis, 10 individuals with MFDH were analyzed by fluorescent in situ hybridization (FISH), but no 22q11.2 deletion was detected. In view of this result, the TBX1 gene located within the 22q11.2 candidate region was screened. A new sequence variant (1132GA) was identified in one patient. This variant was not found in 110 control individuals genotyped. Considering the rarity of this condition and results of this study, the involvement of the 22q11.2 chromosomal region in the pathogenesis of MFDH could not be excluded.
authors.affiliation: Department of Medical Genetics, University of Campinas (UNICAMP), Campinas, SP, Brazil. msimioni@gmail.com
authors.forename: M
authors.initials: M
authors.lastname: Simioni
authors.forename: E Lopes
authors.initials: EL
authors.lastname: Freitas
authors.forename: T Paiva
authors.initials: TP
authors.lastname: Vieira
authors.forename: I
authors.initials: I
authors.lastname: Lopes-Cendes
authors.forename: V Lúcia
authors.initials: VL
authors.lastname: Gil-da-Silva-Lopes
mesh_terms: D002874:Chromosome Mapping; D002892:Chromosomes, Human, Pair 22; D005145:Face / Q000002:abnormalities*; D005260:Female; D014644:Genetic Variation; D006801:Humans; D006972:Hypertelorism / Q000235:genetics*; D008297:Male; D020641:Polymorphism, Single Nucleotide; D017384:Sequence Deletion; D013879:Thioredoxins / Q000235:genetics
chemical_list: C491203:TXN protein, human; D013879:Thioredoxins
references.citation: Int J Dev Biol. 2006;50(5):504-10
references.pmid: 16586352
references.citation: Neuroimage. 2005 Mar;25(1):169-80
references.pmid: 15734353
references.citation: Arq Neuropsiquiatr. 2006 Dec;64(4):916-20
references.pmid: 17220995
references.citation: Am J Hum Genet. 2007 Mar;80(3):510-7
references.pmid: 17273972
references.citation: Arq Neuropsiquiatr. 2007 Jun;65(2B):396-401
references.pmid: 17665003
references.citation: Brain. 2006 May;129(Pt 5):1218-28
references.pmid: 16569671
references.citation: Am J Med Genet. 1997 Mar 31;69(3):287-9
references.pmid: 9096758
references.citation: J Med Genet. 2001 Dec;38(12):E45
references.pmid: 11748311
references.citation: Am J Med Genet. 1998 Feb 3;75(4):443-4
references.pmid: 9482658
references.citation: J Med Genet. 2004 Apr;41(4):e40
references.pmid: 15060116
references.citation: Lancet. 2003 Oct 25;362(9393):1366-73
references.pmid: 14585638
references.citation: Cleft Palate Craniofac J. 2006 Jul;43(4):466-70
references.pmid: 16854205
references.citation: Proc Natl Acad Sci U S A. 2006 May 16;103(20):7729-34
references.pmid: 16684884